1. Home
  2. SCLXW vs MCHPP Comparison

SCLXW vs MCHPP Comparison

Compare SCLXW & MCHPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.21

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Microchip Technology Incorporated

MCHPP

Microchip Technology Incorporated

HOLD

Current Price

$71.18

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLXW
MCHPP
Founded
N/A
N/A
Country
United States
United States
Employees
34
17900
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
MCHPP
Price
$0.21
$71.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.9K
68.9K
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.05
$47.08
52 Week High
$0.64
$88.00

Technical Indicators

Market Signals
Indicator
SCLXW
MCHPP
Relative Strength Index (RSI) 57.95 42.02
Support Level $0.11 $69.48
Resistance Level $0.21 $72.37
Average True Range (ATR) 0.02 2.27
MACD 0.00 -0.42
Stochastic Oscillator 100.00 23.75

Price Performance

Historical Comparison
SCLXW
MCHPP

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About MCHPP Microchip Technology Incorporated

Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

Share on Social Networks: